Skip to main content

Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure])

Publication ,  Conference
Feldman, T; Mauri, L; Kahwash, R; Litwin, S; Ricciardi, MJ; van der Harst, P; Penicka, M; Fail, PS; Kaye, DM; Petrie, MC; Basuray, A; Lilly, S ...
Published in: Circulation
January 23, 2018

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circulation

DOI

EISSN

1524-4539

ISSN

0009-7322

Publication Date

January 23, 2018

Volume

137

Issue

4

Start / End Page

364 / 375

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Feldman, T., Mauri, L., Kahwash, R., Litwin, S., Ricciardi, M. J., van der Harst, P., … Shah, S. J. (2018). Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]). In Circulation (Vol. 137, pp. 364–375). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1161/circulationaha.117.032094
Feldman, Ted, Laura Mauri, Rami Kahwash, Sheldon Litwin, Mark J. Ricciardi, Pim van der Harst, Martin Penicka, et al. “Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]).” In Circulation, 137:364–75. Ovid Technologies (Wolters Kluwer Health), 2018. https://doi.org/10.1161/circulationaha.117.032094.
Feldman T, Mauri L, Kahwash R, Litwin S, Ricciardi MJ, van der Harst P, et al. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]). In: Circulation. Ovid Technologies (Wolters Kluwer Health); 2018. p. 364–75.
Feldman, Ted, et al. “Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]).” Circulation, vol. 137, no. 4, Ovid Technologies (Wolters Kluwer Health), 2018, pp. 364–75. Crossref, doi:10.1161/circulationaha.117.032094.
Feldman T, Mauri L, Kahwash R, Litwin S, Ricciardi MJ, van der Harst P, Penicka M, Fail PS, Kaye DM, Petrie MC, Basuray A, Hummel SL, Forde-McLean R, Nielsen CD, Lilly S, Massaro JM, Burkhoff D, Shah SJ. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]). Circulation. Ovid Technologies (Wolters Kluwer Health); 2018. p. 364–375.

Published In

Circulation

DOI

EISSN

1524-4539

ISSN

0009-7322

Publication Date

January 23, 2018

Volume

137

Issue

4

Start / End Page

364 / 375

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology